SFCL
CPRX

Strengthening Families & Communities LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Strengthening Families & Communities LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-90
Closed -$2.1K – 607
2025
Q4 		$2.1K Buy
+90
New +$2K ﹤0.01% 320
2025
Q3 		– Sell
-15
Closed -$364 – 714
2025
Q2 		$364 Buy
+15
New +$354 ﹤0.01% 364

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Strengthening Families & Communities LLC's CPRX Position: Q1 2026 in Review

Strengthening Families & Communities LLC sold out of Catalyst Pharmaceutical (CPRX) in Q1 2026, closing a stake of 90 shares — an estimated $2.1K sold.

Strengthening Families & Communities LLC first reported a position in CPRX in Q2 2025 and held it in 2 quarters. The position peaked at $2.1K in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Strengthening Families & Communities LLC reported no remaining Catalyst Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Strengthening Families & Communities LLC sold 90 Catalyst Pharmaceutical shares in Q1 2026, an estimated $2.1K.
  • Strengthening Families & Communities LLC first reported a position in Catalyst Pharmaceutical in Q2 2025 and held it in 2 quarters.
  • Strengthening Families & Communities LLC's Catalyst Pharmaceutical position peaked at $2.1K in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q1 2026, filed 11 May 2026.